Meyka Pro banner
Fidelity Leveraged Company Stock Fund

Stay Updated with the Latest Fidelity Leveraged Company Stock Fund FLVCX News in Real Time

Find FLVCX news now at Meyka AI. Stay informed with the latest Fidelity Leveraged Company Stock Fund stocks updates, including price news, market analysis, and expert insights.

FLVCX●NASDAQ
Financial ServicesAsset Management - Leveraged
$51.74
$2.25(4.17%)
U.S. Market opens in 8h 16m
Moderna Soars 177% After Melanoma Vaccine Clears Phase 3 Trial on August 20
πŸ“… in about 5 hours

Moderna Soars 177% After Melanoma Vaccine Clears Phase 3 Trial on August 20

Moderna stock jumped 177% after its melanoma vaccine met Phase 3 trial endpoints. The personalized mRNA therapy showed significant improvements over standard treatment in over 1,100 patients.

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update
πŸ“… in about 4 hours

Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update

Moderna jumped 177% to $174.38 after Phase 3 melanoma vaccine trial success with Merck. The mRNA therapy reduced recurrence risk and represents the first approved late-stage cancer vaccine.

Read more 12
xAI Founder Tony Yuhuai Wu Buys Rs 670 Crore California Mansion After 6 Years in AI
πŸ“… in about 1 hour

xAI Founder Tony Yuhuai Wu Buys Rs 670 Crore California Mansion After 6 Years in AI

xAI co-founder Tony Yuhuai Wu reportedly buys Rs 670 crore Villa de Verano mansion in California with nine-hole golf course and 150-seat amphitheatre after six years in AI.

Read more 12
Moderna Soars 177% After Melanoma Vaccine Clears Late-Stage Trial on August 19
πŸ“… in 39 minutes

Moderna Soars 177% After Melanoma Vaccine Clears Late-Stage Trial on August 19

Moderna jumps 177% and Merck gains 12% after their personalized mRNA cancer vaccine met key goals in a Phase 3 melanoma trial, the first positive late-stage result for an mRNA cancer therapy.

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12%
πŸ“… 11 minutes ago

Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12%

Moderna jumped 177% and Merck rose 12% after announcing the first Phase 3 win for an mRNA cancer vaccine. The personalized treatment reduced melanoma recurrence risk significantly.

Read more 12
Bitcoin Hits $70K as Treasury Buyback Sparks $1.23B Short Squeeze on August 19
πŸ“… 31 minutes ago

Bitcoin Hits $70K as Treasury Buyback Sparks $1.23B Short Squeeze on August 19

Bitcoin jumped 5.8% to $69,500 on August 19 as the U.S. Treasury doubled bond buybacks and Trump met with crypto executives at the White House to push the CLARITY Act.

Read more 12
Alibaba Sells Lingxi Games for $1.5B, Pivots to AI on August 20
πŸ“… 4 hours ago

Alibaba Sells Lingxi Games for $1.5B, Pivots to AI on August 20

Alibaba sells gaming unit Lingxi Games to Trustar Capital for USD 1.5 billion, redirecting capital to AI and cloud infrastructure as part of CEO Wu Yongming’s business restructuring.

Read more 12
Russians Pull €24.4B From Banks in 7 Months as War Fears Mount
πŸ“… 10 hours ago

Russians Pull €24.4B From Banks in 7 Months as War Fears Mount

Russians withdrew €24.4 billion from banks in the first seven months of 2026, fearing the Kremlin will seize deposits to finance the Ukraine war. Five of Russia’s seven largest banks recorded net outflows.

Read more 12
Great Western Highway Reopens Q2 2027 After $200M Federal-State Funding Boost
πŸ“… 10 hours ago

Great Western Highway Reopens Q2 2027 After $200M Federal-State Funding Boost

Federal and NSW governments commit $200 million to rebuild Great Western Highway at Victoria Pass, with reopening targeted for Q2 2027 and a new overtaking lane to follow.

Read more 12

FLVCX News FAQ